Use of Estradiol Valerate or 17B estradiol in combination with Dienogest in oral Therapy for maintaining and / or implement Female Libido

摘要

THE INVENTION IS RELATED TO THE USE OF ESTRADIOL VALERATE OR 17BETA-ESTRADIOL (ESTRADIOL) IN COMBINATION WITH 17ALFA-CYANOMETIL-17-BETA-HYDROXIESTRA-4,9-DIEN-3-ONA (DIENOGEST) IN A MULTIPLE COMBINED PRODUCT OR ONLY ONE PHASE IN AN ORAL THERAPY TO MAINTAIN AND / OR INCREASE THE FEMALE LIBIDO, WHEN IT WAS APPROPRIATE ALSO WITH AN ORAL CONTRACEPTION. THE TOTAL DAILY DOSE UNITS OF THE COMBINATION OF MULTIPLE PHASES AND THE PHARMACEUTICALLY ACCEPTABLE PLACEBO OR THE DAILY DOSE UNITS OF THE COMBINATION OF A SINGLE PHASE AND WITHOUT ACTIVE INGREDIENT AND WITHOUT PLACEBO CORRESPOND TO 28 DAYS